What is useful about noncompartmental analysis? (Ep. 46)

https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/d8/b7/53/d8b7535e-304b-2a45-9101-6a0dba275877/mza_4959011917654003018.jpg/600x600bb.jpg

Clinical Pharmacology Podcast with Nathan Teuscher

Nathan Teuscher

50 episodes

1 week ago

I discuss clinical pharmacology and pharmacometrics topics from the perspective of drug development scientists. I share my expertise and knowledge about designing and conducting clinical pharmacology studies and discuss how to analyze the data using the most effective approaches. I draw from my experience of over 20 years working in drug development organizations and consultancies.

Life Sciences

Science

RSS

All content for Clinical Pharmacology Podcast with Nathan Teuscher is the property of Nathan Teuscher and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Life Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo/37913298/37913298-1685396967693-8969d77a8b51c.jpg

What is useful about noncompartmental analysis? (Ep. 46)

Clinical Pharmacology Podcast with Nathan Teuscher

27 minutes 10 seconds

4 months ago

What is useful about noncompartmental analysis? (Ep. 46)

In this episode I discuss noncompartmental analysis. I categorize PK parameters calculated by NCA methods as either Important, Useful, or Questionable. I also share my thoughts on how to report PK parameters calculated using NCA methods in nonclinical and clinical reports. I want to hear your thoughts about this episode. Do you agree or disagree with my categorization of PK parameters? Why? Use the links below to let me know.

Links discussed in the show:

You can connect with me on LinkedIn and send me a message
Send me a message
Sign up for my newsletter